surmount-1 tirzepatide trial obesity without diabetes once weekly for the treatment of in people with type 2 (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 Tirzepatide for Obesity: Highlights from

This prevents the frustration of running out mid-protocol and helps you time refill orders

Yes, under medical supervision

If you have been on a stable maintenance dose for approximately 12 weeks with persistent, intense hunger and inadequate weight loss (less than 5% body weight), this warrants comprehensive review of your treatment plan

A half-pound per week in months 6 through 12 is completely normal and still represents significant progress over time

How Should You Store Mounjaro

Our board-certified obesity medicine providers will provide personalized weight management guidance and prescribe weight loss medications as part of your tailored weight loss strategy